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Canine angiostrongylosis is an increasingly reported disease in Europe which can be fatal if left untreated. The wide range of
clinical presentation along with the absence of pathognomonic alterations can make the diagnosis challenging; thus any additional
information that may provide clues to an early diagnosis may be of value, in order to ensure adequate anthelmintic treatment. Aim
of the study was to assess a clinicopathological scoring system associated with naturalAngiostrongylus vasorum infection diagnosed
in canine patients during clinical practice, to clinically and paraclinically monitor infected dogs after treatment, and to monitor the
presence of L1 larvae in faecal samples by Baermann’s test. Of the total 210 enrolled animalsA. vasorum infection was diagnosed in 7
dogs.These dogs were clinically and paraclinically investigated andmonitored after specific treatment. Further 3 symptomatic dogs
were retrospectively included in the monitoring. Results suggest that the computed scoring system can help to increase the clinical
suspicion of infection particularly in asymptomatic dogs before the onset of potentially lethal lesions. Data of faecal monitoring
suggested that treatment may control parasite burden but be unable to eradicate infection. Thus, a continued faecal monitoring
after treatment is advisable for identification of still infected or reinfected dogs.
1. Introduction
Canine angiostrongylosis is an increasingly reported disease,
possibly due to climatic factors [1], to the presence of foxes
acting as parasite reservoir in urban areas [2] or increased
travelling of dog owners with their animals [3] which may
have facilitated the spread and establishment of the parasite,
or, more simply, to more accurate diagnostic methods [4]. In
Italy, data on the prevalence of canine angiostrongylosis are
scant [5]; however, cases have been recently reported [6–10],
suggesting a spread of the infection into previously free areas.
The parasite Angiostrongylus vasorum defined as the
“great imitator” [11] is responsible for different clinical
pictures; anyway the infection is generally associated with
respiratory signs, occasionally coupled with neurological and
coagulation disorders [12]. The severity of symptoms can
greatly vary ranging from asymptomatic to severe forms [7,
11–13]. Laboratory [14–16], radiographic [17, 18], echocardio-
graphic [19–21], and thoracic computer tomographic abnor-
malities [22, 23] are nonspecific.
The gold standard to achieve the diagnosis still remains
the first-stage larvae (L1) detection using the Baermann
technique on faecal samples, preferably collected over three
consecutive days because of the intermittent larval detection
in faeces [24]. Molecular tests on different materials have
been developed to improve diagnosis [25–28] and highly sen-
sitive and specific ELISA able to detect circulating antigens as
well as specific antibodies in sera sample of infected dogs have
also been developed [29, 30].
Treatment of canine angiostrongylosis is performed
through oral weekly application of milbemycin oxime for
four weeks [31] or a single application of a combination of
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moxidectin with imidacloprid in a spot-on formulation
(Im/Mox) [32], while oral administration of fenbendazole is
widely used in different dosages and over several days and
appears to be effective but is unlicensed [18]. Infections with
A. vasorum are of great importance in veterinary medicine,
being potentially fatal if left untreated [7, 11, 33]. On the basis
of the current literature, the wide range of clinical presenta-
tion alongwith the absence of pathognomonic alterations can
make the diagnosis challenging, and itmight be hypothesized
that a high number of asymptomatic infections are misdi-
agnosed in endemic areas. Since pathological changes can
be present even before clinical signs [16, 32], any additional
information that may provide clues to an early diagnosis
may be of value, in order to ensure adequate anthelmintic
treatment.
Therefore, the aims of this work were to assess a clin-
icopathological score associated with natural A. vasorum
infection diagnosed in canine patients; to collect the clinical,
laboratory, and imagining data associated with natural A.
vasorum infection and follow up animals after treatment; and
to monitor the presence of L1 in faecal samples evaluated by
Baermann’s test in a long term followup after treatment.
2. Materials and Methods
2.1. Study Design, Procedures. From November 2010 to
November 2011 a faecal sample was routinely collected
directly from the rectal ampulla of owned dogs presented for
different problems or for a routine control visit at the Clinical
Unit of the Veterinary Faculty of Bari, Italy. In case of empty
ampulla, a fresh faecal sample was collected by the owner.
Dogs of all ages, breeds, and living conditions were
randomly enrolled in the study, except for animals living
exclusively in apartments, which were excluded. Anamnestic
data including dog history, living conditions, location, and
date and duration of travelling into other regions or abroad
as well as the medical history were collected and registered
on individual clinical forms, along with data from clinical
examination performed at the enrolment. A direct faecal
smear was prepared and microscopically examined and the
Baermann technique was performed. For patients tested
negative but which during the clinical examination showed a
clinicopathological score equal to or higher than 3 (see below)
the direct faecal smear examination and the Baermann test
were also performed on a 3-day faecal pool. Positive dogs
were enrolled in the clinical study and treated (Section 2.2).
The infection was monitored by means of Baermann’s tests
(Section 2.3).
For each dog clinicopathological changes suggestive
for angiostrongylosis were evaluated and expressed with
a score obtained by adding points as follows: presence of
signs of coagulation deficits, respiratory disease, neurological
signs: 3 points each; laboratory alterations such as ane-
mia (hematocrit < 36%), leukocytosis (leukocytes > 17 ×
103/𝜇L), mild eosinophilia (eosinophils 1.2–1.8 × 103/𝜇L),
hyperglobulinaemia (>4.4 g/dL), or specific increase of 𝛽
globulin (𝛽
1
+ 𝛽
2
> 1.7 g/dL) and any abnormalities in
hemostatic parameters: 1 point each; severe eosinophilia
(eosinophils > 1.8 × 103/𝜇L), lung interstitial/alveolar pat-
tern on thoracic radiographs, pulmonary hypertension at
echocardio-Doppler examination: 3 points each. Dogs living
in the same environment of diagnosed positive dogswere also
enrolled in the study, to which a score of 3 was assigned.
The Baermann technique was performed with 5 g of
faeces, with reading at 24 hours. Faecal samples positive
for the presence of moving nematode larvae were sent to
the Parasitology Unit of the same faculty for morphological
identification following McGarry and Morgan [34].
2.2. Clinical Followup on Positive Dogs. Each dog positive at
faecal examinations was included in the clinical follow-up
study. An accurate physical examination and thoracic radio-
graphs, echocardiography, routine laboratory examinations
(CBC, biochemical tests, and serum protein electrophoresis),
and a coagulation profile were performed in these dogs before
anthelmintic treatment as already described [35].
Further 3 symptomatic dogs (dogs 8-9-10) with a previous
diagnosis of canine angiostrongylosis on faecal examination
were included in the clinical study; their medical records and
radiographs were retrospectively reviewed and clinical and
paraclinical findings collected.
Asymptomatic dogs were treated with an imidaclo-
prid/moxidectin spot-on formulation (Im/Mox) in a dosage
of 25mg moxidectin/kg BW at T
0
, T
+15
, T
+30
(Advocate
spot-on; Bayer, Animal Health). Symptomatic dogs were
treated with fenbendazole 25mg/kg BW/12 hourly/per os
for 21 days (Panacur, Intervet, Animal Health). In symp-
tomatic animals clinical examination was performed once
a week until clinical recovery, afterwards twice a month,
while asymptomatic animals were reexamined only after
the third spot-on treatment. Laboratory, radiographic, and
echocardiographic controls were performed after treatment
according to owner disposability.
2.3. Faecal Monitoring of A. vasorum Infections. After treat-
ment, dogs were weekly monitored using the Baermann test
on a 3-day faecal pool, both in symptomatic and asymp-
tomatic animals, for one month, afterwards once a month
until possible, firstly depending on owner compliance. When
infection persisted, a second-line treatment was considered
(i.e., Im/Mox spot-on once a month associated with fenben-
dazole 25mg/kg BW/per os daily for 21 days).
The studymonitoringwas stoppedwhennormalization of
any clinicopathological alterations and/or 2 consecutive par-
asitological negative results were reached. The animals were
kept under their usual housing conditions and handled and
sampled with the owners’ consent and with the approval of
the Ethical Committee of the Faculty of Veterinary Medicine
of the University of Bari (Bari, Italy).
3. Results
3.1. Score Assignment andDiagnosis of Infection. A total of 210
owned dogs were enrolled in the study. The study population
consisted of 97 females and 113 males; 84 were crossbred and
126 purebred animals. The age ranged between 4 months
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Table 1: (a) Clinicopathological changes indicating potential infections withAngiostrongylus vasorum in a random dog population (𝑛 = 210)
and the corresponding number of dogs confirmed by faecal Baermann examination; (b) scoring of dogs with clinico-pathological changes
indicating potential infections with Angiostrongylus vasorum in a random dog population (𝑛 = 210) and the corresponding number of dogs
confirmed by faecal Baermann examination.
(a)
Clinicopathological changes Dogs with change (𝑛) A. vasorum positive dogs (𝑛)
Signs of coagulation deficits 2 1
Respiratory disease 30 1
Neurological signs 14 1
Anemia (hematocrit < 36%) 25 1
Leukocytosis (leukocytes > 17 × 103/𝜇L) 16 2
Mild eosinophilia (eosinophils 1.2–1.8 × 103/𝜇L) 13 1
Hyperglobulinaemia (>4.4 g/dL) 4 0
Specific increase in 𝛽 globulin (𝛽
1
+ 𝛽
2
> 1.7 g/dL) 57 4
Any abnormalities in hemostatic parameters 15 1
Severe eosinophilia (eosinophils > 1.8 × 10
3
/𝜇L) 6 2
Lung interstitial/alveolar pattern on thoracic radiographs 3 3
Pulmonary hypertension at echocardio-Doppler examination 1 0
Shared environment with positive dogs 17 1
(b)
Score No. of dogs (of which A. vasorum is positive (𝑛))
0 77
1 40 (1)
2 19
3 42 (1)
4 22 (1)
5 6 (1)
6 1
7 —
8 1 (1)
9 1 (1)
10 —
11 1 (1)
and 16 years (mean 6.2 years) and the weight ranged from
1 to 55Kg (mean 22.9 Kg). The clinical and pathological
abnormalities and scores for dogs included in the study are
reported in Table 1. To a total of 74 dogs a clinical score ≥ 3
was assigned.
A direct faecal smear was evaluated in all enrolled dogs
(210 samples) and Baermann’s test was performed on 162
single samples; in the other 48 dogs the sample volume
was not enough to perform the test. A 3-day faecal pool
was investigated by means of both direct fecal smear and
Baermann’s test, in 67 out of 74 dogs showing a clinical score
≥ 3, depending on owner compliance. On the whole, 7 dogs
resulted positive for A. vasorum larvae at least at one test (see
Table 2).A. vasorum infectionwas diagnosed in six dogs from
ampulla and/or single fresh faecal samples. The Baermann
test performed on the 3-day faecal pool revealed that one
further dogwas infected.Among the seven positive dogs only
one single dog, presented for a routine control visit, had a
score< 3 (dog 2).Thehighest score (11)was reached by a hunt-
ing dog (dog 6) presenting severe dyspnoea, while a score of
9 was reached by a dog (dog 7) presented for epistaxis and
hyphema. The remaining five positive dogs were normal at
clinical examination; nevertheless, they reached a score ≥ 3.
3.2. Clinical Followup. Dogs positive forA. vasorum infection
(𝑛 = 10) (Table 3) were aged between nine months and
12 years. All dogs were from central-southern Italy and had
nevermoved out of the area. Clinical and paraclinical features
at presentation are described in a wider case series study else-
where [35]. Briefly, the owner complaint was heterogeneous:
dyspnea, polypnea, mild/severe coughing, gradual distension
of the abdomen, epistaxis, and acute unilateral hyphema. Five
caseswere presented for routine control visits and one case for
specific ocular examination. Among paraclinical alterations
the most interesting were a variable increase in 𝛽 globulin
fraction at serum protein electrophoresis in all, except for
two, dogs and the serpiginous/circular areas of radiopacity
revealed at thoracic radiographs in asymptomatic dogs as
already described [35].
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Table 2: Breed, sex (M: male, F: female), age (y: years, m: months), clinical pathological score, and results of diagnostic tests (neg: negative,
pos: positive, and nd: not determined) of 7 dogs resulting positive to Angiostrongylus vasorum infection.
Dog Score Score single points∗∗ Direct smear Single sample,Baermann
Three-day pool
direct smear
Three-day pool,
Baermann
1∗ German Shepherd M, 2 y, 32 kg 4 ↑WBC, 1
↑EOS, 3 neg pos neg neg
2∗ Crossbred M, 4 y, 31 kg 1 ↑ 𝛽1𝛽2, 1 neg pos nd nd
3 Crossbred sterilized F, 4 y, 31 kg 8
Rx, 3
Environment, 3
↑ 𝛽1 + 𝛽2, 1
↑EOS, 1
neg pos nd nd
4∗ Crossbred sterilized F, 12 y, 26 kg 5
Rx, 3
↑ 𝛽, 1
↓AT, ↑fibr., 1
neg pos neg neg
5 Labrador F, 6, 5 y, 29 kg 3 Seizures, 3 pos nd neg pos
6 Breton F, 1 y, 18 kg 11
Dyspnea, 3
Rx, 3
↑WBC, 1
↑EOS, 3
↑ 𝛽, 1
neg neg neg pos
7 Crossbred M, 9m, 15 kg 9
coagulation deficit
signs, 3
Rx, 3
↓HCT, 1
↓PLT, 1
↑ 𝛽1𝛽2, 1
pos pos nd nd
Total 2/7 5/6 0/4 2/4
∗Animals presented for routine control visit.
∗∗See Materials and Methods section.
Fenbendazole was administered in monotherapy in five
cases; Im/Moxwas administered inmonotherapy in the other
five cases (Table 3). In general, clinical pictures significantly
improved in all symptomatic dogs after 1-2weeks of treatment
and the remission of radiographic abnormalities, when avail-
able, was registered at different times.
3.3. Faecal Monitoring. Results of faecal monitoring are
reported in Table 4. In three dogs a second-line treatment
was needed because of the persistence of positive results on
fecal samples after 12 weeks from treatment beginning (dog 2
and 3) or because a reverse to positive results was registered
during monitoring (dog 5). Fenbendazole 25mg/kg/day for
21 days associated with Im/Mox was used as second-line
treatment. In these three dogs a long term monitoring was
performed.
4. Discussion
Given the geographical difference with the previously
reported case series [9] and prevalence studies [5, 10] from
Italy, this study documents the apparent spread of the
parasite in this country. The clinicopathological score has
been proposed to increase the chances to detect infected dogs.
It has been formulated on the basis of the most commonly
described clinical and paraclinical alterations associated with
A. vasorum infection in the literature [4, 15, 17, 20, 21]. Sharing
the same environment of infected dogs has been included in
the scoring system because it suggests the potential presence
of affected gastropods vectors in that area.
Combining the scoring system with faecal tests intro-
duced as routine tests in clinical practice permitted to
identify asymptomatic dogs. Diagnosis of angiostrongylosis
was performed in all dogs by L1 detection in faecal samples
and identification based on morphometric characters and
measurements [34]. The occasional detection of L1 in the
faeces of dogs referred for a routine control visit suggests that
faecal samples can reveal asymptomatic subjects, as previ-
ously shown [11]. Our results show that testing three-day fecal
pools only partially improved the diagnostic chance to reveal
infection, as reported in recent prevalence studies [36, 37].
The reported cases show different clinical presentations
associated with the presence of A. vasorum in dogs, con-
firming that angiostrongylosis should be considered as a
possible etiological cause of several from mild to severe
clinical conditions [11]. As previously described, pathological
paraclinical findings have been registered in both symp-
tomatic and asymptomatic dogs. In particular the increase
in 𝛽 globulin fraction at serum protein electrophoresis and
the serpiginous/circular areas of radiopacity on thoracic
radiographs were documented as useful findings that may
help to reveal asymptomatic infections [35].
Given its proven efficacy [12, 38], fenbendazole has been
used in symptomatic patients, whereas Im/Mox was used for
asymptomatic dogs or dogs without life-threatening clinical
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Table 4: Results of faecal monitoring by Baermann’s test. The asterisks show the passage to a second-line treatment (fenbendazole
25mg/kg/os/daily for 21 days plus Im/Mox spot-on once a month) for dogs 2, 3, and 5.
Dog number 1 2 3 4 5 6 7 8 9 10
Faecal monitoring
1 week nd + + − nd − + + + −
2 weeks − + nd + + − − − + −
3 weeks nd + nd − + − − − − −
4 weeks − + + − nd nd − − − −
6 weeks nd + + − + nd nd
8 weeks nd + + − − nd nd
12 weeks − +∗ +∗ nd − nd nd
16 weeks − − − − −
20 weeks − +∗ nd
24 weeks −
Second-line treatment Fenb. + Im/Mox Fenb. + Im/Mox Fenb. + Im/Mox
Faecal monitoring
2 weeks + nd +
3 weeks nd + nd
4 weeks + nd −
6 weeks + + nd
8 weeks + − −
20 week − − nd
24 week nd nd +
28 week − − −
44 week − −
signs in this study. All dogs treated with fenbendazole (dogs
6–10) resulted negative at Baermann after 1-2 weeks of treat-
ment but a long term monitoring was available only in two
dogs (dogs 6, 7), showing negative results. A highly variable
response was registered in dogs treated with Im/Mox (dogs 1–
5). Two dogs (dogs 1 and 4) reached negative results 1-2 weeks
after first spot-on administration and persisted negative for 16
and 20 weeks, respectively. It is reported that larval excretion
may continue for over 3 weeks, even if anthelmintic treatment
was successful [16]. One case (dog 5) slowly reached negative
results (8 weeks after the first spot-on) but it became again
positive two times during monitoring, 20 and 24 weeks after
the first- and second-line treatment, respectively. The other
two cases (dogs 2 and 3) resulted persistently positive for
12 weeks. For these persistently positive dogs, reinfection or
coprophagiamay be assumed.The last three dogswere treated
with a second-line treatment. Cases 2 and 3 achieved negative
results slowly (8 and 20 weeks after second-line treatment)
making a direct association with treatment efficacy difficult,
while they persisted negative in a long term followup. Case 5
showed negative results 4 weeks after second-line treatment
but unexpectedly the dog reversed to positive a second
time. Reinfection or uncontrolled infection with only partial
efficacy treatment is possible, as well as coprophagia leading
to false positive results. The question remains open. It may
be suggested that anthelmintic treatments may not always
completely eliminate adult worms but be able to sterilise
them, as shown for Dirofilaria immitis infections, possibly
leading to a reduced pathogenicity of A. vasorum infections.
In experimental studies [16] comparing dogs treated with
Im/Mox spot-on and untreated dogs, eggs and larvae were
only present in untreated dogs. In the same study, larval
excretion stopped within 20 days in all 4 treated dogs [16].
However, as evidenced by the same authors, dogs were
infected once, whereas in nature dogs can repeatedly ingest
infected snails. Oliveira-Ju´nior and colleagues [24] reported
on the larval output of dogs infected and reinfected with A.
vasorum presenting continuous or irregular pattern in larval
output.
The highly variable response to treatment registered in
this study suggests that under natural conditions several fac-
tors could affect the response to treatment and the diagnosis
of A. vasorum infections, possibly associated with the host
and/or to the parasite biology. Moreover, to monitor the
response to treatment, serial tests are needed since the limits
of Baermann’s tests are known and a single negative result
does not mean absence of larval excretion.
5. Conclusions
Assessing a clinicopathological score can help to increase the
clinical suspicion of infection particularly in asymptomatic
dogs before the onset of potentially lethal lesions. Early
detection of infected dogs is important because pathological
changes may be already present in asymptomatic dogs [32].
Furthermore, the identification of asymptomatic dogs is an
important task to reduce the risk of parasite importation in
free areas due to trips of animals from endemic areas to
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free regions [39]. Thus, a move towards routine diagnostic
screening in healthy dogs is auspicable. Faecal monitoring
after treatment confirmed what was already stated: treatment
may control parasite burden but be unable to eradicate
infection [40]; thus, continued monitoring after treatment is
advisable for identification of still infected or reinfected dogs
or for differentiation between infections and coprophagia.
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